Literature DB >> 11778797

Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.

A Chetta1, G Pisi, A Zanini, A Foresi, G L Grzincich, M Aiello, A Battistini, D Olivieri.   

Abstract

The six-minute walking test (6MWT) has been widely utilized to evaluate global exercise capacity in patients with cystic fibrosis. The aim of this study was to assess the exercise capacity by 6MWT, measuring four outcome measures: walk distance, oxygensaturation and pulse rate during the walk, and breathlessness perception after the walk, in a group of cystic fibrosis adults with mild to moderate lung disease, and in healthy volunteers, as the control group. Moreover, the study examined the relationship between 6MWT outcome measures and pulmonary function in patients. Twenty-five adults (15 females, age range 18-39 years) with cystic fibrosis and 22 healthy volunteers (14 females, age range 20-45 years) performed a 6MWT following a standard protocol. Walk distance, oxygen saturation (SpO2) and pulse rate at rest and during walk, and breathlessness perception after walk assessed by visual analogue scale (VAS) were measured. Cystic fibrosis patients did notdiffer from healthy volunteers in walk distance (626 +/- 49 m vs. 652 +/- 46 m) and pulse rate. Patients significantly differed from healthy volunteers in SPO2 during the walk (mean SpO2) (P < 0.0001) and VAS (P < 0.0001). In patients, SPO2 during the walk significantly correlated with forced expiratory volume in 1 sec (FEV1) (P < 0.0001), residual volume (RV) (P < 0.001), resting SPO2 (base SpO2) (P < 0.001), and inspiratory capacity (IC) (P < 0.01). In addition, VAS significantly correlated with resting SPO2 (P < 0.01) and IC (P < 0.01). On the basis of regression equations by stepwise multiple regression analysis, SpO2 during walk was predicted by FEV1 (r2 = 0.60) and VAS by IC (r2 = 0.31), whereas walk distance was not reliably predicted by any assessed variables. This study showed that cystic fibrosis adults with mild to moderate lung disease covered a normal walk distance with unimpaired cardiac adaptation, but experienced a significant fall in oxygen saturation and an increased breathlessness perception during exercise. Resting pulmonary function was related to oxygen saturation and breathlessness perception during walk, but contributed significantly only tothe prediction of oxygen saturation. We suggest that 6MWT could be valuable for identifying patients who might experience oxygen desaturation and dyspnoea during demanding daily activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11778797     DOI: 10.1053/rmed.2001.1194

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Exercise testing in cystic fibrosis: why (and how)?

Authors:  D S Urquhart
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

2.  Objective and Subjective Sleep Efficiency in Adult Patients with Cystic Fibrosis and Impact on Quality of Life.

Authors:  Marta Íscar-Urrutia; Claudia Janeth Madrid-Carbajal; Gemma Rubinos-Cuadrado; Ramón Fernández-Álvarez; María José Vázquez-López; Cristina Hernández-González; Ana Isabel Enríquez-Rodríguez; Marta García-Clemente
Journal:  Lung       Date:  2018-10-03       Impact factor: 2.584

3.  THE USE OF ULTRASONOGRAPHY TO EVALUATE MUSCLE THICKNESS AND SUBCUTANEOUS FAT IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS.

Authors:  Rodrigo Pereira de Souza; Márcio Vinícius Fagundes Donadio; João Paulo Heinzmann-Filho; Rafael Reimann Baptista; Leonardo Araújo Pinto; Matias Epifanio; Paulo José Cauduro Marostica
Journal:  Rev Paul Pediatr       Date:  2018 Oct-Dec

4.  Exercise-Induced Oxygen Desaturation during the 6-Minute Walk Test.

Authors:  Raghav Gupta; Gregg L Ruppel; Joseph Roland D Espiritu
Journal:  Med Sci (Basel)       Date:  2020-01-31

5.  Effects of wearing different facial masks on respiratory symptoms, oxygen saturation, and functional capacity during six-minute walk test in healthy subjects.

Authors:  Sauwaluk Dacha; Busaba Chuatrakoon; Kanphajee Sornkaew; Kamonchanok Sutthakhun; Putsamon Weeranorapanich
Journal:  Can J Respir Ther       Date:  2022-06-22

6.  Dyspnea perception in cystic fibrosis patients.

Authors:  B Ziegler; A K Fernandes; P R S Sanches; D P Silva Junior; P R O Thomé; P T R Dalcin
Journal:  Braz J Med Biol Res       Date:  2013-09-24       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.